Ignite Creation Date:
2024-05-06 @ 2:57 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04474470
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2020-06-30
Brief Title:
A Study to Evaluate NT219 Alone and in Combination with ERBITUX Cetuximab in Adults with Advanced Solid Tumors and Head and Neck Cancer
Sponsor:
TyrNovo Ltd
Organization:
Purple Biotech Ltd
Organization Data
Organization:
Purple Biotech Ltd
Class:
INDUSTRY
Study ID:
TYR-219-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
TyrNovo Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None